Rong‐Quan He

4.0k citations
187 papers · 2.9k indexed · h-index 29
Topics
Cancer-related molecular mechanisms research (76 papers)RNA modifications and cancer (59 papers)MicroRNA in disease regulation (52 papers)

In The Last Decade

Rong‐Quan He

170 papers receiving 2.9k citations

Peers

Rong‐Quan He
Comparison fields: 5 of 105
  • Molecular Biology 2.2k
  • Cancer Research 1.8k
  • Pulmonary and Respiratory Medicine 471
  • Oncology 329
  • Surgery 233
Replace Yi‐Wu Dang with:
Yi‐Wu Dang China
Qu Cai China
Jim Dimitroulakos Canada
Tomohiro Arita Japan
Lisha Qi China
Jongchan Kim United States
Min‐Bin Chen China
Ludovica Ciuffreda Italy
Qinwen Zeng United States
Rong‐Quan He relative to Yi‐Wu Dang China Yi‐Wu Dang's profile →
Citations per field
00.5×1.7×
Yi‐Wu Dang · 1×
Citations per year

Countries citing papers authored by Rong‐Quan He

Since Specialization
Citations

This map shows the geographic impact of Rong‐Quan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong‐Quan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong‐Quan He more than expected).

Fields of papers citing papers by Rong‐Quan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong‐Quan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong‐Quan He. The network helps show where Rong‐Quan He may publish in the future.

Co-authorship network of co-authors of Rong‐Quan He

This figure shows the co-authorship network connecting the top 25 collaborators of Rong‐Quan He. A scholar is included among the top collaborators of Rong‐Quan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong‐Quan He. Rong‐Quan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 1
6 4
7 2
8 0
9 0
10 3
11 3
12 6
13 12
14 47
15
Epidemiologic Association of Nonalcoholic Fatty Liver Disease and Urinary Calculi: a Population-based Cross-sectional Study in Southern China.
15
16 3
17 3
18 52
19 4
20 23

About Rong‐Quan He

Rong‐Quan He is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 187 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (76 papers), RNA modifications and cancer (59 papers) and MicroRNA in disease regulation (52 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (2.2k citations) and Pulmonary and Respiratory Medicine (471 citations). Rong‐Quan He has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Gang Chen, Yi‐Wu Dang, Dianzhong Luo, Jie Ma, Xiaohua Hu, Dandan Xiong, Peng Lin, Zhen‐Bo Feng, Minhua Rong and Ruixue Tang. Their work appears in journals such as PLoS ONE, Journal of Leukocyte Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026